Biologics: Targets and Therapy : Impact Factor & More
eISSN: 1177-5491pISSN: 1177-5475
Open AccessShare this on:
Key Metrics
CiteScore 
5.7
SJR
Q2Oncology
SNIP
1.05
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Biologics: Targets and Therapy Journal Specifications
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2390 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2007 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Biologics: Targets and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Biologics: Targets and Therapy
Immunological Biomarkers in Glioblastoma: Targeting T and NK Cells for Enhanced Diagnosis and Prognosis
- 29 May 2026
- Biologics : Targets & Therapy
MicroRNA-661 Suppresses Proliferation and Migration of Pulmonary Artery Smooth Muscle Cells and Endothelial Cells by Targeting CCND2
- 28 May 2026
- Biologics : Targets & Therapy
Vunakizumab and Acitretin for Elderly Refractory Generalized Pustular Psoriasis: A Case Report and Comprehensive Literature Review
- 22 May 2026
- Biologics : Targets & Therapy
Rapid Resolution of Psoriasis Following Low-Dose Interleukin-2 Monotherapy: A Case Report
- 20 May 2026
- Biologics : Targets & Therapy
Long-Term TIE2 Inhibition in a TEK-Mutated Venous Malformation: A 3-Year Clinical Experience
- 19 May 2026
- Biologics : Targets & Therapy
Rheumatoid Factor Beyond Rheumatoid Arthritis: A Potential Marker of Cardiometabolic and Hepatic Risk.
- 1 Apr 2026
- Biologics : targets & therapy
Immunological Biomarkers in Glioblastoma: Targeting T and NK Cells for Enhanced Diagnosis and Prognosis
- 29 May 2026
- Biologics : Targets & Therapy
MicroRNA-661 Suppresses Proliferation and Migration of Pulmonary Artery Smooth Muscle Cells and Endothelial Cells by Targeting CCND2
- 28 May 2026
- Biologics : Targets & Therapy
Vunakizumab and Acitretin for Elderly Refractory Generalized Pustular Psoriasis: A Case Report and Comprehensive Literature Review
- 22 May 2026
- Biologics : Targets & Therapy
Rapid Resolution of Psoriasis Following Low-Dose Interleukin-2 Monotherapy: A Case Report
- 20 May 2026
- Biologics : Targets & Therapy
Long-Term TIE2 Inhibition in a TEK-Mutated Venous Malformation: A 3-Year Clinical Experience
- 19 May 2026
- Biologics : Targets & Therapy
Rheumatoid Factor Beyond Rheumatoid Arthritis: A Potential Marker of Cardiometabolic and Hepatic Risk.
- 1 Apr 2026
- Biologics : targets & therapy
FAQs on Biologics: Targets and Therapy
How long has Biologics: Targets and Therapy been actively publishing? 
What is the publishing frequency of Biologics: Targets and Therapy?
How many articles did Biologics: Targets and Therapy publish last year?
What is the eISSN & pISSN for Biologics: Targets and Therapy?
What is Citescore for Biologics: Targets and Therapy?
What is SNIP score for Biologics: Targets and Therapy?
What is the SJR for Biologics: Targets and Therapy?
Who is the publisher of Biologics: Targets and Therapy?
